Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Abstract Psychosis is the most common neuropsychiatric side-effect of dopaminergic therapy in Parkinson’s disease (PD). It is still unknown which factors determine individual proneness to psychotic symptoms. Schizotypy is a multifaceted personality trait related to psychosis-proneness and dopaminerg...
Main Authors: | Carina R. Oehrn, Jana Schönenkorb, Lars Timmermann, Igor Nenadić, Immo Weber, Phillip Grant |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80765-5 |
Similar Items
-
Binaural acoustic stimulation in patients with Parkinson’s disease
by: Alexander Calvano, et al.
Published: (2023-05-01) -
An Overview of the Association between Schizotypy and Dopamine
by: Christine eMohr, et al.
Published: (2014-12-01) -
NoLiTiA: An Open-Source Toolbox for Non-linear Time Series Analysis
by: Immo Weber, et al.
Published: (2022-06-01) -
A Waveform-Independent Measure of Recurrent Neural Activity
by: Immo Weber, et al.
Published: (2022-03-01) -
The Line between Psychosis and Schizotypy: a case report
by: L. Huerga García, et al.
Published: (2022-06-01)